Objective To explore clinical effects of transcatheter aneurysm embolization and cerebrospinal fluid replacement therapy for the treatment of subarachnoid hemorrhage .Methods Clinical path data of 85 cases of subarachnoid hemorrhage patients from January 2010 to August 2012 were analyzed ,and all were used transcatheter aneurysm embolization and cerebrospinal fluid re-placement therapy to observe the clinical effects .Results A total of 85 patients with 84 cases were cured or improved(98 .82% ) , died in 1 case(1 .18% ) and occur complications in 10 cases(11 .76% ) .68 cases of those were followed up for 0 .5-2 .0 years and no case occurred rebleeding .85 patients were hospitalized for 10 to 40 days ,and the average hospital stay was(17 .5 ± 13 .0)d .Conclu-sion Transcatheter aneurysm embolization is a safe ,effective method treating subarachnoid hemorrhage ,combined with cerebrospi-nal fluid replacement therapy to shorten the course ,reduce complications and improve the cure rate .%目的：探讨动脉瘤栓塞术及脑脊液置换治疗动脉瘤性蛛网膜下腔出血（aSAH）的临床疗效。方法对该院2010年1月至2012年8月收治的85例aSAH患者临床资料进行分析，全部采用动脉瘤栓塞术及脑脊液置换治疗观察其临床效果。结果85例患者痊愈或好转84例（98．82％），其中死亡1例（1．18％），并发症10例（11．76％）；术后68例患者随访0．5～2．0年再无出血发生；85例患者住院时间为10～40d，平均（17．5±13）d。结论动脉瘤栓塞术是治疗aSAH安全、有效的方法，同时使用脑脊液置换法，可缩短病程，减少并发症，提高治愈率。
展开▼
